Skip to content

pro opioid studies

opioid pain medication

Study: Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study

After three months of treatment, the large majority of patients, who were on stable doses, the average pain intensity scores were  unchanged or improved for approximately 70 to 80% of patients.  The most common adverse events were not serious, including constipation and nausea, and the incidence of these events declined over time on treatment.